Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

2218 with DOI

1 strong · 14 moderate · 7 weak

Compilations

12026-04-26T15:56:32.606Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

43last ruled 2026-06-04

0 awaiting a ruling

Issued documents

62026-10-19T20:30:12.379Z

notice · info card · emergency

Searches

121 with no results

queries and counts on the build

Claims checked

8770 supported

70 supported · 17 not

Correspondence

0received

consent field ships in Phase 4

Edges

268

derivations recorded for this entity

Complete over 22 sources, 1 compilation, and 43 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/5-meo-dalt/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-19issueIssued notice
  4. 2026-09-24srcAnalytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives
  5. 2026-09-24srcMetabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine
  6. 2026-09-24srcDevelopment and validation of a rapid LC-MS/MS method for the detection of 182 novel psychoactive substances in whole blood
  7. 2026-09-24srcMetabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS
  8. 2026-09-24srcReceptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.
  9. 2026-09-24srcReceptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs
  10. 2026-09-24srcThe recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): a brief review
  11. 2026-09-24srcSetup of a Serotonin 2A Receptor (5-HT2AR) Bioassay
  12. 2026-09-24srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
  13. 2026-09-24srcA Comprehensive HPLC-MS-MS Screening Method for 77 New Psychoactive Substances, 24 Classic Drugs and 18 Related Metabolites in Blood, Urine and Oral Fluid
  14. 2026-09-24srcLoss of Consciousness and Visual Hallucinations Related to 5-MeO-DALT Intake, a Case Report Confirmed by Toxicological Analyses
  15. 2026-09-24srcLocomotor and discriminative stimulus effects of four novel hallucinogens in rodents
  16. 2026-09-24src5-MeO-DALT: the freebase of N,N-diallyl-5-methoxytryptamine
  17. 2026-09-24srcDelirium due to intoxication from the novel synthetic tryptamine 5-MeO-DALT
  18. 2026-09-24src5-MeO-DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis
  19. 2026-09-24srcPharmacologic Activity of Substituted Tryptamines at 5-HT2A, 5-HT2C, 5-HT1A Receptors and SERT
  20. 2026-09-24src5-Meo-DALT-induced Cyclic Myoclonus (P3.013)
  21. 2026-09-24srcToxicology and Analysis of Psychoactive Tryptamines.
  22. 2026-09-24srcIn vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes.
  23. 2026-09-24src5-Methoxy-DALT - SWGDRUG Monograph
  24. 2026-09-24src5-Methoxy-N,N-diallyltryptamine - WHO ECDD Repository
  25. 2026-09-24src5-MeO-DALT - PsychonautWiki
  26. 2026-09-04issueIssued emergency
  27. 2026-09-04issueIssued info_card
  28. 2026-09-04issueIssued notice
  29. 2026-06-04proposal41 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  30. 2026-06-04publicationPublication — backfill
  31. 2026-04-26revisionRevision 1
  32. 2026-04-26absenceSearched ClinicalTrials.gov for "5-MeO-DALT diallyltryptamine" — no results
  33. 2026-04-26genGeneration — pipeline-v5pipeline-v5
  34. 2026-04-26rungeneration run

The same entries, as forms: six forms.